Molycorp Inc (NYSE: MCP), world’s biggest rare-earth metal mining company outside China, reported wider-than-expected fiscal fourth-quarter losses late on Thursday as the bottom line was hurt by lower prices of rare earth metals, dip in production, increase in costs and a huge goodwill impairment charge linked to the acquisition of rare earth processer Neo Material Technologies back in 2012.
Continue reading MolyCorp Swings into Loss in Q4, To Slash Jobs (MCP)
Shares of RXI Pharmaceuticals Corp. (OTC: RXII), a company engaged in the discovery, development and commercialization of therapies based on its RNAi platform, rallied in trading today. The stock ended the day 13.79% higher at $0.330 on above average volume of 9.30 million. RXII shares touched a 52-week high of $0.36 earlier today. The stock has gained 20% in the last three trading sessions.
Shares of Spirit Airlines Incorporated (NASDAQ: SAVE), an airline company that provides services principally throughout the domestic U.S., have edged higher in trading today. At last check, SAVE shares were trading 2.89% higher at $24.79 on above average volume of 1.23 million. The stock hit a 52-week high of $25.64 earlier today. In the last three trading sessions, SAVE shares have gained more than 4%.
Continue reading Major Gainers and Losers on March 14; SAVE, VHC, DYN, TSLA, IBM, WMT, CVX
Shares of Vera Bradley Inc. (NASDAQ: VRA) slumped on Thursday after the handbag and travel leisure accessories maker provided downbeat outlook on the current quarter and full-year, late last evening. However, fiscal fourth-quarter results exceeded Street’s estimates. For the quarter ended February 2, The Fort Wayne-based Company reported a profit of $25.1 million, or 62 cents a share, up from $20.1 million, or 50 cents a share, in the same period of last fiscal.
Continue reading Major Movers on March 14; VRA, LCUT, EFTC, EBAY, MW, AMZN
Lifetime Brands Inc. (NASDAQ: LCUT) reported on Wednesday that its fiscal fourth-quarter earnings jumped more than two times year-on-year, aided by the recent acquisition. Back in December, Lifetime Brands acquired Fred & Friends which makes kitchen tools.
Continue reading Lifetime Brands Posts Strong Q4 Results, Share Rally (LCUT)
Although the Men’s Wearhouse Inc.’s (NYSE: MW) fiscal fourth-quarter results fell short of Street’s estimates due to “challenging macroeconomic environment”; shares rallied in afterhours trading on Wednesday after the specialty men’s suit maker said that it has hired Jefferies & Co. to help evaluating strategic alternatives for its K&G operations. The Company is inclined focusing more on its Men’s Wearhouse and Moores clothing retailing.
Shares of Dole Food Company Inc. (NYSE: DOLE) slumped on Wednesday after the fruit and vegetable producer late last evening reported that it swung into a loss in its fiscal fourth quarter as fresh fruit sales were impacted due to divestiture while costs associated with the deal weighed on the bottom line.
Continue reading Major Movers on March 13; DOLE, EXPR, NFLX, WAG, COH, DWA
Movie streaming and DVD rental company, Netflix Inc. (NASDAQ: NFLX) announced on Wednesday that it will add new features in its video services which would allow its U.S. subscribers to link their Netflix accounts with Facebook (NASDAQ: FB). As a result, Netflix users will now be able to track viewing history of their Netflix-watching friends on Facebook. Besides, the new feature will also allow Netflix users to share what they have viewed with their Facebook Friends.
Continue reading Netflix U.S. Subscribers Can Now Sync Netflix Accounts with Facebook (NFLX, FB)
Shares of GraphOn Corporation (OTC: GOJO), a developer, marketer, and seller of application virtualization software and cloud computing software for various computer operating systems primarily in the U.S., are soaring in trading today.
Peregrine Pharmaceuticals (NASDAQ: PPHM) reported late on Tuesday fiscal third quarter results which showed losses were less-than-expected as its revenue jumped more than twofold while lower research and development related costs bolstered the bottom line. The Company is now pinning hopes on its lung cancer treatment drug bavituximab whose development came to a halt after questions were raised regarding its efficacy.
Continue reading Peregrine Pharmaceuticals Reports Narrower Q3 Loss (PPHM)